投稿者 | Ahouach, Btisseme; Diaz, Emmanuelle; Bertin, Blandine; Ben Said, Benoit; Combret, Sandrine; Grandvuillemin, Aurelie; Petitpain, Nadine; Rabier, Marie Blanche; Thomas, Laure; Trenque, Thierry; Ingen-Housz-Oro, Saskia; Lebrun-Vignes, Benedicte |
組織名 | Dermatology Department, Henri-Mondor Hospital AP-HP, Creteil, France.;Pharmacovigilance Center, Hospital University Pharmacotoxicology Department,;Hospices Civils de Lyon HCL, Lyon, France.;Dermatology Department, Edouard Herriot Hospital, Lyon, France.;Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL,;Creteil, France.;Pharmacovigilance Department, Dijon University Hospital, Dijon, France.;Pharmacovigilance Department, Nancy-Brabois Hospital, Vandoeuvre-les-Nancy,;France.;Pharmacovigilance Department, Besancon University Hospital, Besancon, France.;Pharmacovigilance Department, Henri-Mondor Hospital AP-HP, Creteil, France.;Pharmacovigilance Department, University Hospitals of Reims, Reims, France.;Univ Paris Est Creteil Epiderme, UPEC, Creteil, France.;Pharmacovigilance Department, Pitie-Salpetriere Hospital, AP-HP, Sorbonne;Universite, Paris, France. |